'The 21st century is Asia's century': PM Modi at ASEAN Summit
Calling ASEAN an epicenter of growth, Modi said that the bloc plays a crucial role in global development

Prime Minister Narendra on Thursday said that the voice of the Global South must be strengthened and called for building a rules-based post-COVID world order at the ASEAN Summit in Jakarta, Indonesia.During his address at the summit, PM Modi also stressed the importance of ensuring a free and open Indo-Pacific.The Association of Southeast Asian Nations (ASEAN) is considered one of the most influential groupings in the region, and India and several other countries including the US, China, Japan and Australia are its dialogue partners.Modi arrived in Jakarta on Thursday morning, saying that it is an "honour" for him to co-chair the ASEAN-India summitIn the address at the Summit in Indonesia, PM Modi congratulated Indonesian President Joko Widodo for organising the Summit and said, "Our partnership has reached the fourth decade. It is an honour for me to co-chair this Summit. I want to congratulate Indonesian President Joko Widodo for organising this Summit."Calling ASEAN an epicenter of growth, Modi said that the bloc plays a crucial role in global development."The 21st century is Asia's century. It is a century of all of us," he said.He added, "It will be mutually beneficial for all of us to develop a rules-based post-Covid world order as well as efforts by all (Sabka Prayas) for human welfare."The prime minister also noted that the ASEAN-India partnership has entered its fourth decade."ASEAN occupies a prominent place in India's Indo-Pacific initiative," he said.With inputs from agencies

US signs landmark nuclear deal with Saudi Arabia amid tensions in West Asia
Wildfires ravage parts of Italy, Spain and France, prompting thousands of evacuations
US set to sign Saudi nuclear deal; Rubio says pact won't fuel proliferation
India-US trade deal 'almost complete', says US after Jaishankar-Rubio talks in Manila
Marco Rubio says he 'would expect India to be concerned' over Trump's pharma tariffs
